Australia adopts ambitious plan to use PrEP to ‘virtually eliminate’ HIV by 2020
Market constraints and uncertainties may limit the scale-up of HIV self-testing
Sofosbuvir/velpatasvir shows high cure rate in HIV/HCV co-infection study
NAM announces new Executive Director
Starting treatment on the day of HIV diagnosis improves retention and viral suppression, Haiti study shows
PrEP can further reduce the risk of HIV infection after a partner starts treatment
Young gay men can do well on PrEP, but may need more support
SEARCH study exceeds 90-90-90 targets after 2 years of 'test and treat' for HIV in rural East Africa
South Africa has driven mother-to-child HIV transmission down to 4%
